Published in Clin Med on February 01, 2014
Acute kidney injury-how does automated detection perform? Nephrol Dial Transplant (2015) 1.00
Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study. PLoS One (2015) 0.96
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis (2016) 0.88
Maximising Acute Kidney Injury Alerts--A Cross-Sectional Comparison with the Clinical Diagnosis. PLoS One (2015) 0.82
Impact of electronic-alerting of acute kidney injury: workgroup statements from the 15(th) ADQI Consensus Conference. Can J Kidney Health Dis (2016) 0.82
Multicentre study of investigation and management of inpatient hyponatraemia in the UK. Postgrad Med J (2014) 0.82
Electronic Alerts for Acute Kidney Injury. Dtsch Arztebl Int (2017) 0.75
Acute Kidney Injury in the Era of the AKI E-Alert. Clin J Am Soc Nephrol (2016) 0.75
Information Technology and Acute Kidney Injury: Alerts, Alarms, Bells, and Whistles. Adv Chronic Kidney Dis (2017) 0.75
Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (2009) 2.47
Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z. PLoS One (2010) 1.62
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther (2005) 1.29
Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother (2005) 1.11
Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments. Assay Drug Dev Technol (2010) 1.10
Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chem Biol (2013) 1.05
Development and optimization of high-throughput in vitro protein phosphatase screening assays. Nat Protoc (2007) 1.01
Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review. J Biomol Screen (2010) 0.96
Requirements, features, and performance of high content screening platforms. Methods Mol Biol (2007) 0.95
Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors. Methods Enzymol (2006) 0.93
High-throughput automated confocal microscopy imaging screen of a kinase-focused library to identify p38 mitogen-activated protein kinase inhibitors using the GE InCell 3000 analyzer. Methods Mol Biol (2009) 0.88
Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform. Methods Enzymol (2006) 0.88
Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits. J Biomol Screen (2010) 0.88
Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation. Methods Enzymol (2006) 0.86
Configuring radioligand receptor binding assays for HTS using scintillation proximity assay technology. Methods Mol Biol (2002) 0.86
Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B. Org Biomol Chem (2008) 0.86
One Year's Observational Study of Acute Kidney Injury Incidence in Primary Care; Frequency of Follow-Up Serum Creatinine and Mortality Risk. Nephron (2015) 0.84
A case study from the chemistry core of the Pittsburgh Molecular Library Screening Center: the Polo-like kinase polo-box domain (Plk1-PBD). Curr Top Med Chem (2009) 0.83
Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2. Assay Drug Dev Technol (2010) 0.82
Relapse of nephrotic syndrome triggered by biphosphonates. Nephrol Dial Transplant (2002) 0.81
Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors. Chem Biol Drug Des (2007) 0.80
Increasing age at diagnosis and worsening renal function in patients with primary central nervous system lymphoma. J Neurooncol (2010) 0.80
Characterization of inhibitors of glucocorticoid receptor nuclear translocation: a model of cytoplasmic dynein-mediated cargo transport. Assay Drug Dev Technol (2011) 0.79
Successful treatment of factor H-related haemolytic uraemic syndrome. Nephrol Dial Transplant (2002) 0.79
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol (2014) 0.77
Sarcoid presenting with hypercalcaemia and erythema nodosum in a haemodialysis patient. Nephrol Dial Transplant (2002) 0.75
High content screening biosensor assay to identify disruptors of p53-hDM2 protein-protein interactions. Methods Mol Biol (2015) 0.75
The impact on resources of increased adequacy targets in haemodialysis. Nephrol Dial Transplant (2002) 0.75
Introduction and welcome to the Society of Biomolecular Imaging and Informatics (SBI²). Assay Drug Dev Technol (2014) 0.75